Side by side
Thymosin Alpha-1 vs Thymosin Beta-4: How They Differ
Same first name, two unrelated molecules. Here is the distinction the internet keeps blurring.
The short version
People constantly mix these up because they share a name, but Thymosin Alpha-1 vs Thymosin Beta-4 is a comparison of two genuinely different molecules. Thymosin Alpha-1 is a 28-amino-acid immune peptide — it helps immune cells mature and coordinate, and its drug form is thymalfasin [1]. Thymosin Beta-4 (sold in research circles as TB-500) is a larger 43-amino-acid peptide that binds a structural protein called actin and is studied for tissue repair, not immunity. They differ in sequence, size, the receptors and proteins they act on, and what researchers use them for. They are not interchangeable, and one is not a "version" of the other. If you came looking for a muscle or recovery peptide, Thymosin Alpha-1 is not it.
Different molecules, not variants
The shared word "thymosin" is historical: both were first found in thymic extracts, but they belong to separate peptide families. Thymosin Alpha-1 is a 28-amino-acid, N-terminally acetylated peptide cleaved from the precursor prothymosin alpha; it has no disulfide bonds and no aromatic residues, and the synthetic drug thymalfasin is sequence-identical [1]. Thymosin Beta-4 is a 43-amino-acid peptide from the beta-thymosin family whose defining job is sequestering monomeric actin inside cells. Their amino-acid sequences are unrelated; knowing one tells you nothing about the other's structure.
Different mechanisms, different uses
Mechanistically they barely overlap. Thymosin Alpha-1 signals through Toll-like receptors on dendritic cells, matures T-cells toward a Th1 program, and engages an IDO-driven regulatory arm — an immunomodulator end to end [5]. Its clinical record is in chronic viral hepatitis, immune restoration, and adjuvant cancer settings [9][7]. Thymosin Beta-4, by contrast, is studied for its roles in cell migration, angiogenesis, and wound healing through actin dynamics — a tissue-repair story, not an immune one. Using one where the other is indicated would be using the wrong tool entirely.
The doping-status difference matters
There is a practical regulatory gap, too. Thymosin Beta-4 (TB-500) is the one explicitly named on the WADA Prohibited List and is the peptide athletes are warned about. Thymosin Alpha-1 is not specifically listed as a named prohibited substance — though immunomodulatory peptides occupy a grey area and the current WADA List should always be the reference. The point for this comparison: the two molecules sit in different places regulatorily as well as biologically. Confusing them is not a harmless naming slip.
Bottom line
Thymosin Alpha-1 vs Thymosin Beta-4 comes down to four clean differences: sequence (unrelated 28-mer vs 43-mer), size, mechanism (immune signalling vs actin binding), and use (viral/immune/cancer adjuvant vs tissue repair). They are not the same compound, not two grades of one product, and not substitutes. This site is about the immune peptide — Thymosin Alpha-1 — and its forward-read but honestly-graded evidence base [3].